Emerging within the pharmaceutical landscape, retatrutide signifies a potential advance in obesity treatment space. This innovative dual agonist targeting both GLP-1 and GIP receptors has shown impressive efficacy in patient trials , implying a enhanced ability to promote fat decrease and improve associated cardiovascular concerns. While current… Read More